大麻二醇的药理和生理影响:剂量升级,安慰剂洗研究协议
J Patrick Neary1,2, Jyotpal Singh3,4, Jane Alcorn5,6
1Faculty of Kinesiology & Health Studies, University of Regina, 3737 Wascana Pkwy, Regina, SK, S4S 0A2, Canada. patrick.neary@uregina.ca.
BMC neurology
|September 12, 2024
概括
这项研究调查了运动员对大麻素 (CBD) 的不断升级剂量,以找到在轻度创伤性脑损伤后潜在的治疗益处的最佳剂量. 这些发现旨在为运动中的CBD使用提供信息,以预防和恢复伤害.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 运动医学 运动医学
背景情况:
- 大麻 (CBD) 具有抗炎性质,对轻度创伤性脑损伤有潜在的治疗应用.
- 有限的研究存在于健康的男性大学运动员中增加CBD剂量的影响.
- 目前没有最佳的CBD剂量方案来增强运动员的生理功能.
研究的目的:
- 根据药理动力学数据,确定接触式运动运动员的最佳大麻素 (CBD) 剂量.
- 将生理和心理数据与药理动力学数据相关联,以阐明CBD剂量升级的机制.
- 探索CBD在减少轻度创伤性脑损伤和增强运动员恢复方面的潜力.
主要方法:
- 40名健康的男性大学运动员将参与这项研究.
- 参与者将在两周的时间间隔内接受CBD (530 mg/kg/day) 的升级剂量.
- 将进行药理,生理 (大脑血液动力学,心血管,神经刺激,基因组学) 和心理 (睡眠,焦虑,疼痛) 评估.
主要成果:
- 药理动力学数据将从10次访问的血液样本中收集.
- 生理学评估包括大脑血动力学,血压,心电图,心震图和TMS.
- 心理评估包括关于睡眠,焦虑和疼痛的验证问卷.
结论:
- 这项研究旨在为运动员确定最佳的CBD剂量.
- 该研究将提供关于CBD在运动员中的药理学,生理学和心理影响的见解.
- 这些发现可能支持使用CBD来缓解轻度创伤性脑损伤,并在运动季节改善恢复.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Drug Administration and Therapy Phases: Overview
416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416


